uk
Feedback
THINK TANK 2.0 🛡️🔮

THINK TANK 2.0 🛡️🔮

Відкрити в Telegram

OTC and Small Cap| Fastest growing premium channel for stock trading ideas and more.

Показати більше
837
Підписники
-124 години
-67 днів
-2130 день
Архів дописів
Fence join up

$WAVE soaring ✈️

https://x.com/i/status/2069888296684073414 $NVDA tweeting about $WAVE 🤯

$WAVE this small cap was featured today on the official NVIDIA Blog! The clean energy company is expected to be a major player in AI infrastructure. https://blogs.nvidia.com/blog/eco-wave-power-ai-digital-twins/

Added some $LBRG. Bottomed in dubs with just 53M DTC. CEO has experience from Toyota, Honda, Panasonic. More news just hit today. Should be over a penny easy with this float. https://www.otcmarkets.com/stock/LBRG/news/Ladybug-Resource-Group-Inc-Solidifies-Market-Dominance-With-Rare-Eco-Certified-Manufacturing-Assets-Anchoring-Global-EV-?id=524742

$ILLR huge news! Yorkville toxic lender is GONE. ✅ No Active Yorkville Equity Line ✅ No New Yorkville Instruments ✅ No Undisc
$ILLR huge news! Yorkville toxic lender is GONE. ✅ No Active Yorkville Equity Line ✅ No New Yorkville Instruments ✅ No Undisclosed Yorkville Dilution Huge step forward for the company.

$ILLR potential wedge breakout setup with nice upper target of .60
$ILLR potential wedge breakout setup with nice upper target of .60

$KULR & their research partner National Laboratory of the Rockies have been awarded NASA's Invention of the Year! https://x.com/KULRTech/status/2056084524417892608?s=20

4hr chart
4hr chart

$DFTC New AI website has launched and it has some very juicy DD. Multi-dimes coming here imo
+2
$DFTC New AI website has launched and it has some very juicy DD. Multi-dimes coming here imo

$KULR really getting the love it deserves now. Monster squeeze building here.
$KULR really getting the love it deserves now. Monster squeeze building here.

$VXIT Holding 200MA on weekly. Golden cross here still possible in the future. First news clearly underwhelming to the market
$VXIT Holding 200MA on weekly. Golden cross here still possible in the future. First news clearly underwhelming to the market. Follow the support levels for now imo. That being said it wasn't negative news, just didn't meet sentiment expectations. More catalysts to come, so opportunity for future moves upwards.

$VXIT Sounds like we're in store for big things. https://x.com/i/status/2052483824077148261

$DFTC next leg up starting now. This baby wants multi-dimes. 👀
$DFTC next leg up starting now. This baby wants multi-dimes. 👀

$AMS Monday could get crazy 👀
$AMS Monday could get crazy 👀

$KULR Highlights from this week: 👨‍💼 Added $MSFT Executive Ben Frank to Board of Directors 🔋 Secured $5M+ Opportunity with
+2
$KULR Highlights from this week: 👨‍💼 Added $MSFT Executive Ben Frank to Board of Directors 🔋 Secured $5M+ Opportunity with initial $1M Purchase Order for KULR ONE Air UAV/Drone batteries. 🚁 Partner Robinson Helicopter secure US Marine Corps contract in collaboration with $LMT

$TELO trials beginning first half of 2026 and notated it will be by a leading U.S. Academic Medical Center. 👀 "The clearance of our IND, including the Phase 1/2 clinical protocol, marks an important step as we advance Telomir-Zn into clinical evaluation," said Erez Aminov, CEO of Telomir. "Triple-negative breast cancer remains one of the most difficult cancers to treat in the advanced or metastatic setting, with limited options and consistently poor outcomes. There is a clear need for new therapeutic approaches, and we look forward to evaluating Telomir-Zn in this patient population." Dr. Itzchak Angel, Chief Scientific Advisor, added: "Telomir-Zn is designed to target fundamental aspects of tumor biology through modulation of intracellular metal balance and epigenetic regulation. This metal-epigenetic approach represents a differentiated therapeutic strategy that may have relevance not only in triple-negative breast cancer but also across broader cancer and age-related disease biology." https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/telomir-pharmaceuticals-announces-fda-clearance-of-ind-for-telomir-zn-1162409